St. Louis, Mo. From the Division of Plastic and Reconstructive Surgery, Washington University School of Medicine, and the Department of Biomedical Engineering, Washington University in St. Louis.
Plast Reconstr Surg. 2013 Apr;131(4):499e-511e. doi: 10.1097/PRS.0b013e31828275b7.
Successful nerve regeneration is critical to the functional success of composite tissue allografts. The present study was designed to characterize the effect of acute rejection on nerve regeneration and functional recovery in the setting of orthotopic limb transplantation.
A rat orthotopic limb transplantation model was used to evaluate the effects of acute rejection on nerve regeneration and motor recovery. Continuous administration of FK506 (full suppression), administration of FK506 for the first 8 of 12 weeks (late rejection), or delayed administration of FK506/dexamethasone following noticeable rejection (early rejection) was used to preclude or induce rejection following limb transplantation. Twelve weeks postoperatively, nerve regeneration was assessed by means of histomorphometric analysis of explanted sciatic nerve, and motor recovery was assessed by means of evoked muscle force measurement in extensor digitorum longus muscle.
A single episode of acute rejection that occurs immediately or late after reconstruction does not significantly alter the number of regenerating axonal fibers. Acute rejection occurring late after reconstruction adversely affects extensor digitorum longus muscle function in composite tissue allografts.
Collected data reinforce that adequate immunosuppressant administration in cases of allogeneic limb transplantation ensures levels of nerve regeneration and motor functional recovery equivalent to that of syngeneic transplants. Prompt rescue following acute rejection was further demonstrated not to significantly affect nerve regeneration and functional recovery postoperatively. However, instances of acute rejection that occur late after reconstruction affect graft function. In total, the present study begins to characterize the effect of immunosuppression regimens on nerve regeneration and motor recovery in the setting of composite tissue allografts.
成功的神经再生对于复合组织同种异体移植物的功能成功至关重要。本研究旨在描述急性排斥反应对同种异体肢体移植中神经再生和功能恢复的影响。
使用大鼠同种异体肢体移植模型评估急性排斥反应对神经再生和运动恢复的影响。连续给予 FK506(完全抑制)、在前 12 周的第 8 天给予 FK506(晚期排斥)或在明显排斥后给予 FK506/地塞米松延迟给药(早期排斥),以避免或诱导肢体移植后的排斥反应。术后 12 周,通过对移植的坐骨神经进行组织形态计量学分析评估神经再生,通过测量伸趾长肌的诱发肌肉力量评估运动恢复。
单次急性排斥反应,无论是在重建后立即发生还是晚期发生,都不会显著改变再生轴突纤维的数量。重建后晚期发生的急性排斥反应会对复合组织同种异体移植物中的伸趾长肌功能产生不利影响。
收集的数据进一步证实,同种异体肢体移植中充分的免疫抑制剂给药可确保神经再生和运动功能恢复达到与同基因移植相当的水平。急性排斥反应后及时进行抢救,术后不会显著影响神经再生和功能恢复。然而,重建后晚期发生的急性排斥反应会影响移植物功能。总的来说,本研究开始描述免疫抑制方案对复合组织同种异体移植物中神经再生和运动恢复的影响。